Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 3Not yet recruiting 3Completed 2Unknown 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Advanced Solid Tumor 2

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × glumetinib × Clear all
NCT03457532 2024-11-01

A Phase I Study of SCC244 in Patients with Advanced MET Alterations Solid Tumors

Haihe Biopharma Co., Ltd.

Phase 1 Completed
177 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT03466268 2024-10-09

Study to Evaluate the Safety and Anti-tumor Activity of SCC244

Haihe Biopharma Co., Ltd.

Phase 1 Completed
56 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡